NeuroPace Files 8-K: Other Events & Exhibits

Ticker: NPCE · Form: 8-K · Filed: Feb 18, 2025 · CIK: 1528287

Neuropace Inc 8-K Filing Summary
FieldDetail
CompanyNeuropace Inc (NPCE)
Form Type8-K
Filed DateFeb 18, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: 8-K, regulatory-filing

TL;DR

NeuroPace filed an 8-K on Feb 14th for 'Other Events' - details TBD.

AI Summary

NeuroPace, Inc. filed an 8-K on February 18, 2025, reporting an event that occurred on February 14, 2025. The filing pertains to "Other Events" and "Financial Statements and Exhibits" but does not provide specific details on the nature of these events or any associated financial figures within the provided text.

Why It Matters

This 8-K filing indicates a material event or change for NeuroPace, Inc., requiring disclosure to investors. However, the specific nature of the event is not detailed in the provided excerpt.

Risk Assessment

Risk Level: medium — The filing of an 8-K often signifies important corporate developments, but the lack of specific details in this excerpt makes it difficult to assess the immediate risk.

Key Players & Entities

  • NeuroPace, Inc. (company) — Registrant
  • February 14, 2025 (date) — Date of earliest event reported
  • February 18, 2025 (date) — Date of Report
  • 455 N. Bernardo Avenue (address) — Principal executive offices
  • Mountain View, CA (location) — Principal executive offices location
  • 94043 (zip_code) — Principal executive offices zip code
  • 6502372700 (phone_number) — Registrant's telephone number

FAQ

What specific 'Other Events' are being reported by NeuroPace, Inc. in this 8-K filing?

The provided text of the 8-K filing does not specify the details of the 'Other Events'.

What are the 'Financial Statements and Exhibits' being filed by NeuroPace, Inc.?

The provided text of the 8-K filing indicates that 'Financial Statements and Exhibits' are part of the filing but does not list their specific contents.

When was the earliest event reported in this 8-K filing?

The earliest event reported in this 8-K filing occurred on February 14, 2025.

What is NeuroPace, Inc.'s principal executive office address?

NeuroPace, Inc.'s principal executive office is located at 455 N. Bernardo Avenue, Mountain View, CA 94043.

What is the Commission File Number for NeuroPace, Inc.?

The Commission File Number for NeuroPace, Inc. is 001-40337.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on February 18, 2025 regarding NeuroPace Inc (NPCE).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.